In a major regulatory move, the Government of India has banned oral Nimesulide formulations above 100 mg in immediate-release form. The decision was officially announced through Gazette Notification S.O. 6091(E) dated 29 December 2025. (Click Here) This ban…
Recent Post
- CDSCO Notifies Final Guidance Document on Medical Device Software (MDSW)
- When a “+” Sign Isn’t Just a Plus
- DCC intends to tighten control on manufacturing and supply of printed packaging materials used for drugs
- High-Alcohol Oral Formulations Move Into Schedule H1
- DCC Recommends Comprehensive Regulatory Mechanism to Curb Unapproved Drugs and FDCs
